top of page
Valuations
Investing in life sciences is unique - long-term returns, environmental uncertainty and development risks require a different approach to establishing arbitrage opportunities, understanding market risks and valuing assets
​
We help you understand which markets to target, how much your technology is worth, assess and mitigate environmental risks and how to enhance the value of your portfolio
​
We also work with investors - we assist in validating your financial models through critical assessments and provide commercial due diligence for your investments, giving you an external perspective on the opportunities and risks with a potential investment
​
Valuation Services:
​
-
Holistic market assessments and sizing
-
Asset valuations and NPV analysis
-
Risk assessment modelling
-
Risk-adjusted forecasting and valuations
-
Identification of value drivers
-
Portfolio review and valuation
-
Critical assessments and commercial due diligence
​
Case Studies​​
​
Private Equity Fund
Pre-Deal Critical Assessment
A European Private Equity firm engaged us to perform a critical assessment of their valuation model and assumptions prior to completing a sizeable investment into a Neurology Start-up
​
With time of the essence, we provided expert advice on revenue and OPEX assumptions within tight timelines to allow our client to successfully close the investment
Private Investor
Company Valuation
A private investor and founder of an early-stage biotech engaged us to conduct a valuation of his business, which included two assets in pre-clinical and phase I
​
We provided a comprehensive analysis and financial model to identify key value inflection points of the individual indications as well as the firm as a whole
bottom of page